A total of 111 (58 %) of the patients were on anti-fungal therapy at the time of bronchoscopy.
Anti-fungal therapy was administer to 10/11 (90.9 %) of the patients with proven or probable IFD and 32/42 (76.2 %) patients with possible IFD, respectively.